Anil Dubala

500 total citations
15 papers, 414 citations indexed

About

Anil Dubala is a scholar working on Endocrinology, Diabetes and Metabolism, Pharmacology and Cellular and Molecular Neuroscience. According to data from OpenAlex, Anil Dubala has authored 15 papers receiving a total of 414 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Endocrinology, Diabetes and Metabolism, 5 papers in Pharmacology and 4 papers in Cellular and Molecular Neuroscience. Recurrent topics in Anil Dubala's work include Diabetes Treatment and Management (7 papers), Antibiotics Pharmacokinetics and Efficacy (4 papers) and Peptidase Inhibition and Analysis (3 papers). Anil Dubala is often cited by papers focused on Diabetes Treatment and Management (7 papers), Antibiotics Pharmacokinetics and Efficacy (4 papers) and Peptidase Inhibition and Analysis (3 papers). Anil Dubala collaborates with scholars based in India, United States and Malaysia. Anil Dubala's co-authors include Jayasankar Kosaraju, Santhivardhan Chinni, Duraiswamy Basavan, Chaitanya Chakravarthi Gali, R. M. Damian Holsinger, SubbaRao V. Madhunapantula, Vishakantha Murthy, Malay K. Samanta, M. N. Satish Kumar and Elango Kandasamy and has published in prestigious journals such as Neuropharmacology, Phytotherapy Research and Journal of Pharmacy and Pharmacology.

In The Last Decade

Anil Dubala

15 papers receiving 403 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Anil Dubala India	9	185	130	89	88	83	15	414
Duraiswamy Basavan India	13	251 1.4×	153 1.2×	91 1.0×	104 1.2×	76 0.9×	49	610
Santhivardhan Chinni India	8	178 1.0×	137 1.1×	81 0.9×	93 1.1×	60 0.7×	17	453
Shahab Ghaderi Iran	13	52 0.3×	92 0.7×	39 0.4×	47 0.5×	49 0.6×	22	502
Fadhel A. Alomar Saudi Arabia	12	41 0.2×	64 0.5×	36 0.4×	52 0.6×	31 0.4×	31	638
D.K. Arulmozhi India	13	169 0.9×	75 0.6×	28 0.3×	48 0.5×	41 0.5×	18	512
Carlos Fernandes‐Lopes Portugal	11	54 0.3×	153 1.2×	105 1.2×	41 0.5×	75 0.9×	24	754
Sonia Gallego‐Sandín Spain	13	44 0.2×	104 0.8×	28 0.3×	120 1.4×	173 2.1×	17	632
Nadia M. S. Arafa Egypt	12	89 0.5×	69 0.5×	12 0.1×	44 0.5×	50 0.6×	21	379
Nadeem Sayyed Saudi Arabia	13	61 0.3×	51 0.4×	19 0.2×	57 0.6×	85 1.0×	55	417
Margaret Binnie United Kingdom	15	327 1.8×	77 0.6×	29 0.3×	18 0.2×	116 1.4×	23	848

Countries citing papers authored by Anil Dubala

Since Specialization

Citations

This map shows the geographic impact of Anil Dubala's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anil Dubala with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anil Dubala more than expected).

Fields of papers citing papers by Anil Dubala

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anil Dubala. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anil Dubala. The network helps show where Anil Dubala may publish in the future.

Co-authorship network of co-authors of Anil Dubala

This figure shows the co-authorship network connecting the top 25 collaborators of Anil Dubala. A scholar is included among the top collaborators of Anil Dubala based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anil Dubala. Anil Dubala is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

15 of 15 papers shown

Kumar, K. Satheesh, et al.. (2022). Topologically directed confocal Raman imaging (TD-CRI): Advanced Raman imaging towards compositional and micromeritic profiling of a commercial tablet components. Journal of Pharmaceutical and Biomedical Analysis. 210. 114581–114581. 9 indexed citations

Wadhwani, Ashish, Ramesh C. Gupta, Pavan Kumar Chintamaneni, et al.. (2018). An effective treatment approach of DPP-IV inhibitor encapsulated polymeric nanoparticles conjugated with anti-CD-4 mAb for type 1 diabetes. Drug Development and Industrial Pharmacy. 44(7). 1120–1129. 8 indexed citations

Dubala, Anil, Ankur Gupta, & Malay K. Samanta. (2014). Combination of monoclonal antibodies and DPP-IV inhibitors in the treatment of type 1 diabetes: A plausible treatment modality?. Medical Hypotheses. 83(1). 1–5. 2 indexed citations

Dubala, Anil, et al.. (2014). Simultaneous Liquid Chromatography–Mass Spectrometry Quantification of Cefixime and Clavulanic Acid in Human Plasma. Journal of Chromatographic Science. 53(5). 694–701. 12 indexed citations

Chinni, Santhivardhan, et al.. (2014). Effect of Crude Extract of Eugenia jambolana Lam. on Human Cytochrome P450 Enzymes. Phytotherapy Research. 28(11). 1731–1734. 8 indexed citations

Dubala, Anil, et al.. (2014). Pharmacokinetics and tissue distribution of a M1 muscarinic acetylcholine receptor positive allosteric potentiator, benzyl quinolone carboxylic acid. Analytical Methods. 6(8). 2672–2678. 2 indexed citations

Kosaraju, Jayasankar, et al.. (2014). P3‐409: DIPEPTIDYL PEPTIDASE‐4 INHIBITION BY PTEROCARPUS MARSUPIUM AND EUGENIA JAMBOLANA AMELIORATES STREPTOZOTOCIN‐INDUCED ALZHEIMER'S DISEASE. Alzheimer s & Dementia. 10(4S_Part_21). 1 indexed citations

Kosaraju, Jayasankar, et al.. (2013). A molecular connection ofPterocarpus marsupium, Eugenia jambolanaandGymnema sylvestrewith dipeptidyl peptidase-4 in the treatment of diabetes. Pharmaceutical Biology. 52(2). 268–271. 18 indexed citations

Dubala, Anil, et al.. (2013). Simultaneous pharmacokinetic assessment of cefadroxil and clavulanic acid in human plasma by LC–MS and its application to bioequivalence studies. Journal of Pharmaceutical Analysis. 3(4). 285–291. 18 indexed citations

10.

Dubala, Anil, et al.. (2013). Simultaneous quantification of cefpodoxime proxetil and clavulanic acid in human plasma by LC–MS using solid phase extraction with application to pharmacokinetic studies. Journal of Chromatography B. 921-922. 49–55. 18 indexed citations

11.

Kosaraju, Jayasankar, Chaitanya Chakravarthi Gali, Anil Dubala, et al.. (2013). Saxagliptin: A dipeptidyl peptidase-4 inhibitor ameliorates streptozotocin induced Alzheimer's disease. Neuropharmacology. 72. 291–300. 160 indexed citations

12.

Kosaraju, Jayasankar, et al.. (2013). Vildagliptin: an anti-diabetes agent ameliorates cognitive deficits and pathology observed in streptozotocin-induced Alzheimer's disease. Journal of Pharmacy and Pharmacology. 65(12). 1773–1784. 121 indexed citations

13.

Dubala, Anil, et al.. (2012). BIOANALYTICAL METHOD DEVELOPMENT AND VALIDATION OF SITAGLIPTIN PHOSPHATE BY RP-HPLC AND ITS APPLICATION TO PHARMACOKINETIC STUDY. 18 indexed citations

14.

Dubala, Anil. (2012). Bioequivalence Study of Simvastatin. Journal of AIDS & Clinical Research. 1(11). 2 indexed citations

15.

Dubala, Anil, et al.. (2011). Pharmacokinetic drug interaction between gemfibrozil and sitagliptin in healthy Indian male volunteers. European Journal of Clinical Pharmacology. 68(5). 709–714. 17 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact